Case study

Pharma Commercial Analytics Two core questions that constantly come up in pharma commercial analytics: How big, and what is the profile of our patient population? How many patients are there…

Executing smart marketing and sales tactics requires deep knowledge of the target – here’s how Galileo Cosmos™ patient flow analytics facilitates that process... Key Principles Tactical execution of sales and…

Building commercial coherence from strategy to tactics requires integrated data analysis – here’s how Galileo Cosmos™ facilitates that process... Key Principles Strategic planning is the bedrock on which all product…

“Later-line” products are those products that are launched with a label that requires that other treatments be tried before they are prescribed. Forecasting them is a challenge. Key Principles Forecasting…

Using data to help manage solutions Almost patient involved in the opioid crisis starts their use because of a genuine medical need. Chronic pain due to a long term condition,…

In recent years the number of adverse events being reported through the FDA Adverse Event Reporting System (FAERS) has generally increased as a result of broader reporting requirements and greater…

Complex patient analysis – discovering the patient cohorts that make the difference (part 3) Patients are very complex things to analyse and unfortunately most of our analyses don’t touch on…

Precision medicine is here to stay and our task of understanding pharma/bio markets is becoming yet more complicated. This presentation, given by Simon Fitall at the recent PMRG CONNECT meeting,…

A practical solution to understanding how healthcare providers treat complex and rare diseases Galileo Analytics Co-Founder and CEO gave this presentation at the meeting in Frankfurt in 2016. The presentation…